GLPwatch
Papers (9189)
Page 128 of 154, ranked by citation count.
- Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.
- A case report of severe adverse reaction of exenatide: Anaphylactic shock.
- Oral Semaglutide: A Step Forward in Cardiovascular Risk Management for Type 2 Diabetes.
- Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.
- Functional hydrophilic polystyrene beads with uniformly size and high cross-linking degree facilitated rapid separation of exenatide.
- Decreased complexity of glucose dynamics in diabetes in rhesus monkeys.
- Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip.
- Extended-release exenatide (Bydureon) for type 2 diabetes.
- The impact of extended release exenatide as adjuvant therapy on hemoglobin A1C, weight, and total daily dose of insulin in patients with type 2 diabetes mellitus using U-500 insulin.
- Substitution of insulin by exenatide in bad controlled type 2 diabetic patients: efficacy and predictive factors.
- Incretin-based approaches for type 2 diabetes therapy: effects on circulating cytokines and adipocyte's secretome.
- Liraglutide for patients with non-alcoholic steatohepatitis.
- Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after initiation.
- Orforglipron: A Novel Oral GLP-1 Agonist for the Treatment of Obesity and Diabetes.
- Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes.
- Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis.
- Comparison of Exendin-4 and Its Single Amino Acid Substitutions as Parent Peptides for GLP-1 Receptor Imaging Probes.
- Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents.
- Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes.
- Exploring Dietary Intake in Adults with Type 2 Diabetes Using GLP-1 Receptor Agonists: A Cross-Sectional Analysis.
- Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetes.
- NICE approves liraglutide for diabetic patients not achieving glucose control.
- Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real-world retrospective study.
- The effects of liraglutide and metformin treatment on fracture healing in partially insulinopenic diabetic rats.
- Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes.
- A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol.
- The Obesity Drug Revolution: New Frontiers in Pharmacotherapy.
- Comments to the Editor Concerning the Paper Entitled "Mitochondrial Dysfunction in Diabetic Cardiomyopathy: Effect of Mesenchymal Stem Cell with PPAR-γ Agonist or Exendin-4" Mohamed Abd Elaziz Wassef et al.
- Efficacy of once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes.
- Gastrointestinal side effects of the non-peptide GLP-1 receptor agonists: A systematic review and meta-analysis.
- GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023.
- Comparative Safety of GLP-1 Receptor Agonists Across Gastrointestinal, Renal and Pancreatic Systems.
- Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.
- [GLP-1-based medications: Mechanisms involved in obesity treatment].
- A Descriptive Analysis from VigiAccess on Drug-related Problems Associated with the Glucagon-like Peptide-1 Receptor Agonists.
- The nuclear option for insulinomas.
- Liraglutide for weight management: benefits and risks.
- Liraglutide effect on epicardial fat: Missing the forest for the trees.
- Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review.
- "Why you should (not) use semaglutide?": A critical discourse analysis on health professionals' videos of semaglutide for weight loss on Douyin.
- Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway.
- Novel Antidiabetic Therapies and Cardiovascular Risk Reduction: The Role of the Noninferiority Trial.
- Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications.
- Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study.
- Do GLP-1 Receptor Agonists Care if You Have Heart Failure?
- Efficacy and safety of dapagliflozin and liraglutide in patients with type 2 diabetes mellitus and newly diagnosed as overweight/obese.
- Liraglutide prevents body and fat mass gain in ovariectomized Wistar rats.
- Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.
- Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway.
- Mechanisms of efficacy of drug therapy in type 2 diabetes: the role of microbiomes.
- Navigating compounded semaglutide: what health care providers need to know.
- Seizure recurrence after GLP-1 receptor agonist initiation in adults with epilepsy.
- Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured population.
- Remission of diabetes mellitus type 2 with severe hyperglycemia after Exenatide treatment.
- A microporous liraglutide-releasing silk fibroin scaffold improves islet transplantation outcomes through anti-inflammatory effect.
- Acute Kidney Injury After Accelerated Dosing of Tirzepatide in a Patient with Multiple Comorbidities: A Case Report.
- Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder.
- [Efficacy and safety of IdegLira for the intensification of type 2 diabetes treatment].
- PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
- Dulaglutide rescues the elevated testicular dysfunction in a mouse model of high-fat diet-induced obesity.